SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ARL6IP1 mutation causes congenital insensitivity to pain, acromutilation and spastic paraplegia.
|
28471035 |
2018 |
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders.
|
24482476 |
2014 |
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders.
|
24482476 |
2014 |
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Spastic Paraplegia
|
0.410 |
Biomarker
|
disease |
BEFREE |
This report highlights the role of ARL6IP1 in the pathophysiology of insensitivity to pain and spastic paraplegia.
|
28471035 |
2018 |
Spastic Paraplegia
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
This report highlights the role of ARL6IP1 in the pathophysiology of insensitivity to pain and spastic paraplegia.
|
28471035 |
2018 |
Spastic Paraplegia
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
|
17199135 |
2007 |
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Global analysis of differentially expressed genes in androgen-independent prostate cancer.
|
17199135 |
2007 |
Sensory neuropathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Polyneuropathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gait, Scissors
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperactive patellar reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Polyneuropathy, Motor
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Difficulty walking
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Reflex, Ankle, Absent
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the Achilles tendon
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the knee
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Arteriosclerosis
|
0.050 |
Biomarker
|
disease |
BEFREE |
Approach and Results: We detected a normal AIP1 form (named AIP1A) in the healthy aorta, but a shorter form of AIP1 (named AIP1B) was found in diseased aortae that contained atherosclerotic plaques and graft arteriosclerosis.
|
31619063 |
2020 |
Arteriosclerosis
|
0.050 |
Biomarker
|
disease |
BEFREE |
AIP1 Suppresses Transplant Arteriosclerosis Through Inhibition of Vascular Smooth Muscle Cell Inflammatory Response to IFNγ.
|
30471213 |
2019 |
Arteriosclerosis
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
<b>Objective:</b> AIP1 expression is downregulated in human atherosclerotic plaques and global deletion of AIP1 in mice exacerbates atherosclerosis in ApoE-KO mouse models.
|
29731721 |
2018 |
Arteriosclerosis
|
0.050 |
Biomarker
|
disease |
BEFREE |
AIP1-mediated stress signaling in atherosclerosis and arteriosclerosis.
|
25732743 |
2015 |
Arteriosclerosis
|
0.050 |
Biomarker
|
disease |
BEFREE |
AIP1 prevents graft arteriosclerosis by inhibiting interferon-γ-dependent smooth muscle cell proliferation and intimal expansion.
|
21700930 |
2011 |
Henoch-Schoenlein Purpura
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Our report shows that the phenotype associated with ARL6IP1 variants may be broader and more acute than so far reported and identifies fatal HSP as the severe end of the phenotypic spectrum of ARL6IP1 variants.
|
31272422 |
2019 |